Elrad, which produces medical products, and is controlled by Rosebud International, plans to issue its shares on Wall Street in the summer, at a company value of $120 million.
Elrad Analytical Systems, which develops monitors to measure gases in patients during medical treatment, raised $3.2 million in March through a private placement. This sum reflects a company value of $38 million. Elrad intends shortly to raise capital on Wall Street at a company value of $120 million.
Following the placement, the largest shareholder in Elrad, the holding company Rosebud, holds 26.4% of the company’s shares, which are recorded on its balance sheet at a value of just NIS 8 million. Other shareholders in the company include physicist George Yariv (20.8%), investment company Yishal (9.35%), Evergreen International (8.65%), and Gmul Investment Company (8.41%). Yariv, Yishal, and Evergreen have the possibility of joining in the Wall Street issue through an offer for sale.
Published by Israel's Business Arena on May 14, 1998